We are live on ! Find out more
GKOS icon

Glaukos

178 hedge funds and large institutions have $2.5B invested in Glaukos in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more call options, than puts

Call options by funds: $19M | Put options by funds: $7.81M

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

64% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 45

37% more capital invested

Capital invested by funds: $1.82B → $2.5B (+$677M)

5.74% more ownership

Funds ownership: 107%112.74% (+5.7%)

7% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 27

2% less funds holding

Funds holding: 181178 (-3)

Holders
178
Holders Change
-3
Holders Change %
-1.66%
% of All Funds
3.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
25
Increased
74
Reduced
45
Closed
27
Calls
$19M
Puts
$7.81M
Net Calls
+$11.2M
Net Calls Change
+$16.7M

GKOS Hedge Fund Activity: Q3 2020 in Review

178 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Glaukos (GKOS) for Q3 2020, worth a combined $2.5B — up 37% from $1.82B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of GKOS and 25 opened new positions — a net loss of 2 holders — while 45 trimmed existing stakes and 74 added.

The largest buyer was Brown Capital Management, adding an estimated $83M. The largest seller was OrbiMed, exiting entirely with an estimated $46.5M sold.

  • 178 institutional investors held Glaukos (GKOS) as of Q3 2020, down from 181 in Q2 2020.
  • Funds reported $2.5B of Glaukos stock for Q3 2020, up 37% quarter-over-quarter.
  • 25 funds opened new Glaukos positions in Q3 2020 and 27 closed out, a net change of -2 holders.
  • The largest Glaukos buyer in Q3 2020 was Brown Capital Management, an estimated $83M added.
  • The largest Glaukos seller in Q3 2020 was OrbiMed, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2020.